The Valley Desk

Clinical trial reportCurrent medical research and opinionPublished

Assessment of patient-reported depression severity in subpopulation of ESCAPE-TRD study: esketamine nasal spray versus quetiapine extended release for treatment-resistant depression

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

Publication record

Type
Clinical trial report
Venue
Current medical research and opinion
Published
Subject terms
Humans; Ketamine; Antidepressive Agents; Delayed-Action Preparations; Treatment Outcome; Severity of Illness Index; Adult; Middle Aged; Female; Male; Nasal Sprays; Depressive Disorder, Treatment-Resistant
PubMed ID
40953132
Added to directory
Source checked

Report a correction or request removal